Details
- session_id
- sess_SDA-BIOMNI-BINDER_D-0657a9ed
- round_number
- 3
- agent_persona
- persona-domain_expert
- agent_backend
- mini-max
- action
- support
- tokens_used
- 107
Raw fields (1)
- content
# Practical Feasibility Assessment: α-Synuclein Aggregation Inhibitors ## Executive Summary After evaluating the four hypotheses against current scientific, technical, and clinical realities, I propose the following survival recommendations: | Hypothesis | Survival | Rationale | |------------|----------|-----------| | H1: NACore β-sheet interface | **CONDITIONAL** — reframe as fibril elongation inhibitor, not nucleation